T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients

Journal of Autoimmunity

Volumn 52, Issue , 2014, Pages 113-121

  Marino, Mariapaola ^a   Maiuri, Maria Teresa ^a   Di Sante, Gabriele ^a   Scuderi, Flavia ^a   La Carpia, Francesca ^a   Trakas, Nikolaos ^b   Provenzano, Carlo ^a   Zisimopoulou, Paraskevi ^b   Ria, Francesco ^a   Tzartos, Socrates J ^b   Evoli, Amelia ^a   Bartoccioni, Emanuela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

CDR3; Immunoscope; MHC; Repertoire; Spectratyping; T cell receptor

Indexed keywords

AZATHIOPRINE; CD3 ANTIGEN; CYCLOSPORIN; EDROPHONIUM; EPITOPE; HLA DQ ANTIGEN; HLA DQ5 ANTIGEN; HLA DQB1 ANTIGEN; MUSCLE SPECIFIC TYROSINE KINASE RECEPTOR; MYCOPHENOLIC ACID; NEOSTIGMINE; OLIGOCLONAL BAND; PREDNISONE; T LYMPHOCYTE RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; ANTIGEN; DQ5 PROTEIN; MUSK PROTEIN; PROTEIN; CHOLINERGIC RECEPTOR; HLA-DQ5 ANTIGEN; MUSK PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ADULT; ALLOGENEIC RESTRICTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE IDENTIFICATION; GENE REARRANGEMENT; GENE SEQUENCE; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; MIDDLE AGED; MUSCLE ACTION POTENTIAL; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROMUSCULAR TRANSMISSION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN MOTIF; SCHOOL CHILD; T LYMPHOCYTE; THYMECTOMY; TREATMENT DURATION; ADOLESCENT; CELL CULTURE; DNA SEQUENCE; GENETICS; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE RECEPTOR GENE; YOUNG ADULT;

ADOLESCENT; ADULT; CELLS, CULTURED; CHILD; FEMALE; GENES, T-CELL RECEPTOR; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84904300682     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.12.007     Document Type: Article

References (36)

1. Madhavan R., Zhao X.T., Ruegg M.A., Peng H.B. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering. Mol Cell Neurosci 2005, 28:403-416.
2. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001, 7:365-368.
3. Scuderi F., Marino M., Colonna L., Mannella F., Evoli A., Provenzano C., et al. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement. Lab Invest 2002, 82:1139-1146.
4. Evoli A., Tonali P.A., Padua L., Monaco M.L., Scuderi F., Batocchi A.P., et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003, 126:2304-2311.
5. Guptill J.T., Sanders D.B., Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 2011, 44:36-40.
6. Niks E.H., Kuks J.B., Roep B.O., Haasnoot G.W., Verduijn W., Ballieux B.E., et al. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology 2006, 66:1772-1774.
7. Bartoccioni E., Scuderi F., Augugliaro A., Chiatamone Ranieri S., Sauchelli D., Alboino P., et al. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. Neurology 2009, 72:195-197.
8. Lane P. Molecular mechanisms involved in T-B interactions. Chem Immunol 1997, 67:1-13.
9. Bernard A., Coitot S., Brémont A., Bernard G. Tand B cell cooperation: a dance of life and death. Transplantation 2005, 15(79):S8-S11.
10. Dustin M.L. Adynamic view of the immunological synapse. Semin Immunol 2005, 17:400-410.
11. Miles J.J., Douek D.C., Price D.A. Bias in the alfa beta T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 2011, 89:375-387.
12. Gorski J., Yassai M., Zhu X., Kissela B., Keever C., Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. JImmunol 1994, 152:5109-5119.
13. Ria F., Penitente R., De Santis M., Nicolò C., Di Sante G., Orsini M., et al. Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Res Ther 2008, 10:R135.
14. Truffault F., Cohen-Kaminsky S., Khalil I., Levasseur P., Berrih-Aknin S. Altered intrathymic T-cell repertoire in human myasthenia gravis. Ann Neurol 1997, 41:731-741.
15. Aissaoui A., Klingel-Schmitt I., Couderc J., Chateau D., Romagne F., Jambou F., et al. Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol 1999, 46:559-567.
16. Infante A.J., Baillargeon J., Kraig E., Lott L., Jackson C., Hämmerling G.J., et al. Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. JAutoimmun 2003, 21:167-174.
17. Navaneetham D., Penn A.S., Howard J.F., Conti-Fine B.M. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. JAutoimmun 1998, 11:621-633.
18. Tackenberg B., Kruth J., Bartholomaeus J.E., Schlegel K., Oertel W.H., Willcox N., et al. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur J Immunol 2007, 37:849-863.
19. Dokai H., Nomura Y., Fujikawa Y., Nihei K., Segawa M., Shinomiya N. Astudy of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire. JNeuroimmunol 2007, 187:192-200.
20. Skeie G.O., Apostolski S., Evoli A., Gilhus N.E., Illa I., Harms L., et al. Guidelines for the treatment of neuromuscular transmission disorders. Eur J Neurol 2010, 17:893-902.
21. Trakas N., Zisimopoulou P., Tzartos S.J. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis. JNeuroimmunol 2011, 240-241:79-86.
22. Nicolò C., Di Sante G., Orsini M., Rolla S., Columba-Cabezas S., Romano Spica V., et al. Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune response to self-antigen of the CNS without influencing a 'core' repertoire of specific T cells. Int Immunol 2006, 18:363-374.
23. Rolla S., Nicolò C., Malinarich S., Orsini M., Forni G., Cavallo F., et al. Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice. JImmunol 2006, 177:7626-7633.
24. Penitente R., Nicolò C., Van den Elzen P., Di Sante G., Agrati C., Aloisi F., et al. Administration of PLP139-151 primes T cells distinct from those spontaneously responsive invitro to this antigen. JImmunol 2008, 180:6611-6622.
25. Ria F., Gallard A., Gabaglia C.R., Guéry J.C., Sercarz E.E., Adorini L. Selection of similar naive T cell repertoires but induction of distinct T cell responses by native and modified antigen. JImmunol 2004, 15(172):3447-3453.
26. Currier J.R., Deulofeut H., Barron K.S., Kehn P.J., Robinson M.A. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol 1996, 48:39-51.
27. Quinn A., McInerney M., Huffman D., McInerney B., Mayo S., Haskins K., et al. Tcells to a dominant epitope of GAD65 express a public CDR3 motif. Int Immunol 2006, 18:967-979.
28. Zhang J., Zhang M., Wang Y., Shi B., Zhu B., Si L. Infiltrating T-lymphocyte receptor Vbeta gene family utilization in autoimmune thyroid disease. JInt Med Res 2006, 34:585-595.
29. Zhang X.L., Li Y.Q., Chen S.H., Yang L.J., Chen S., Wu X.L., et al. The feature of clonal expansion of TCR Vbeta repertoire, thymic recent output function and TCRzeta chain expression in patients with immune thrombocytopenic purpura. Int J Lab Hematol 2009, 31:639-648.
30. Klarenbeek P.L., de Hair M.J., Doorenspleet M.E., van Schaik B.D., Esveldt R.E., van de Sande M.G., et al. Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Ann Rheum Dis 2012, 71:1088-1093.
31. Krell P.F., Reuther S., Fischer U., Keller T., Weber S., Gombert M., et al. Next-generation-sequencing-spectratyping reveals public T-cell receptor repertoires in pediatric very severe aplastic anemia and identifies a β chain CDR3 sequence associated with hepatitis-induced pathogenesis. Haematologica 2013, 98:1388-1396.
32. De Rosa M.C., Giardina B., Bianchi C., Carelli Alinovi C., Pirolli D., Ferraccioli G., et al. Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. PLoS One 2010, 5:e11550. 10.1371/journal.pone.0011550.
33. Matsumoto Y., Matsuo H., Sakuma H., Park I.K., Tsukada Y., Kohyama K., et al. CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis. JImmunol 2006, 176:5100-5107.
34. Jones E.Y., Fugger L., Strominger J.L., Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006, 6:271-282.
35. Jambou F., Menestrier M., Klingel-Schmitt I., Caillat-Zucman S., Aïssaoui A., Berrih-Aknin S., et al. Rationale for a T cell receptor peptide therapy in myasthenia gravis. Ann N Y Acad Sci 2003, 998:320-323.
36. Nicolò C., Sali M., Di Sante G., Geloso M.C., Signori E., Penitente R., et al. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis. JImmunol 2010, 184:222-235.